Eyenovia, Inc. (EYEN)
- Previous Close
0.7113 - Open
0.7580 - Bid 0.6227 x 500
- Ask 0.6337 x 300
- Day's Range
0.5964 - 0.7590 - 52 Week Range
0.5010 - 5.8500 - Volume
1,591,945 - Avg. Volume
1,284,541 - Market Cap (intraday)
29.768M - Beta (5Y Monthly) 1.66
- PE Ratio (TTM)
-- - EPS (TTM)
-0.6600 - Earnings Date May 9, 2024 - May 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
7.07
Eyenovia, Inc., an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; and Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is based in New York, New York.
www.eyenovia.comRecent News: EYEN
Performance Overview: EYEN
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EYEN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EYEN
Valuation Measures
Market Cap
29.77M
Enterprise Value
31.00M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.81k
Price/Book (mrq)
3.31
Enterprise Value/Revenue
8.19k
Enterprise Value/EBITDA
-1.29
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-53.09%
Return on Equity (ttm)
-207.83%
Revenue (ttm)
3.79k
Net Income Avi to Common (ttm)
-27.26M
Diluted EPS (ttm)
-0.6600
Balance Sheet and Cash Flow
Total Cash (mrq)
14.85M
Total Debt/Equity (mrq)
178.69%
Levered Free Cash Flow (ttm)
-18.43M
Research Analysis: EYEN
Company Insights: EYEN
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: EYEN
Daily – Vickers Top Buyers & Sellers for 04/01/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Insider Picks for 08/18/2023
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Daily – Vickers Top Buyers & Sellers for 06/24/2022
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Insider Picks for 05/18/2022
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.